Ultragenyx Pharmaceutical (RARE) Earnings Analysis
Ultragenyx Pharmaceutical (RARE) has no confirmed upcoming earnings date. In its last reported quarter (2026-02-12) RARE missed analyst consensus (-7.5% EPS surprise). Trailing P/E -4.52.
Last updated 2026-07-23 · Source: company filings + earnings calendar; consensus from sell-side analyst grades
When does RARE next report earnings?
No confirmed upcoming earnings date is currently scheduled for RARE. This page updates as the calendar is published.
RARE last-quarter earnings result
| Last reported quarter | 2026-02-12 |
|---|---|
| Result vs consensus | Miss (-7.5% EPS surprise) |
RARE consensus estimates and analyst view
Consensus estimates, 8-quarter history and analyst targets are in the SniperIQ app. Create a free account to see them.
Related research pages
More on RARE
Frequently asked questions
When does RARE next report earnings?
RARE has no confirmed upcoming earnings date right now; this page updates as the calendar is published.
Did RARE beat earnings last quarter?
In its 2026-02-12 report, RARE missed analyst consensus (-7.5% EPS surprise).
Where can I see RARE analyst estimates and price targets?
Consensus estimates, 8-quarter history and analyst targets for RARE are in the SniperIQ app: https://app.sniperiq.ai/register